These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26354601)

  • 1. Improving health outcomes through concurrent HIV program scale-up and health system development in Rwanda: 20 years of experience.
    Nsanzimana S; Prabhu K; McDermott H; Karita E; Forrest JI; Drobac P; Farmer P; Mills EJ; Binagwaho A
    BMC Med; 2015 Sep; 13():216. PubMed ID: 26354601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
    Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
    AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell phone-based and internet-based monitoring and evaluation of the National Antiretroviral Treatment Program during rapid scale-up in Rwanda: TRACnet, 2004-2010.
    Nsanzimana S; Ruton H; Lowrance DW; Cishahayo S; Nyemazi JP; Muhayimpundu R; Karema C; Raghunathan PL; Binagwaho A; Riedel DJ
    J Acquir Immune Defic Syndr; 2012 Feb; 59(2):e17-23. PubMed ID: 22067668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRACnet Internet and Short Message Service Technology Improves Time to Antiretroviral Therapy Initiation Among HIV-infected Infants in Rwanda.
    Kayumba K; Nsanzimana S; Binagwaho A; Mugwaneza P; Rusine J; Remera E; Koama JB; Ndahindwa V; Johnson P; Riedel DJ; Condo J
    Pediatr Infect Dis J; 2016 Jul; 35(7):767-71. PubMed ID: 27031258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a case management program for HIV clients in Rwanda.
    Thurman TR; Haas LJ; Dushimimana A; Lavin B; Mock N
    AIDS Care; 2010 Jun; 22(6):759-65. PubMed ID: 20461574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.
    Franke MF; Kaigamba F; Socci AR; Hakizamungu M; Patel A; Bagiruwigize E; Niyigena P; Walker KD; Epino H; Binagwaho A; Mukherjee J; Farmer PE; Rich ML
    Clin Infect Dis; 2013 May; 56(9):1319-26. PubMed ID: 23249611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care.
    van Griensven J; De Naeyer L; Uwera J; Asiimwe A; Gazille C; Reid T
    BMC Pediatr; 2008 Oct; 8():39. PubMed ID: 18831747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality along the continuum of HIV care in Rwanda: a model-based analysis.
    Bendavid E; Stauffer D; Remera E; Nsanzimana S; Kanters S; Mills EJ
    BMC Infect Dis; 2016 Dec; 16(1):728. PubMed ID: 27905895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and construct validity of three health-related self-report scales in HIV-positive adults in rural Rwanda.
    Epino HM; Rich ML; Kaigamba F; Hakizamungu M; Socci AR; Bagiruwigize E; Franke MF
    AIDS Care; 2012; 24(12):1576-83. PubMed ID: 22428702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effectiveness of combination antiretroviral therapy and prevalence of HIV drug resistance in HIV-1-infected children and adolescents in Rwanda.
    Mutwa PR; Boer KR; Rusine J; Muganga N; Tuyishimire D; Schuurman R; Reiss P; Lange JM; Geelen SP
    Pediatr Infect Dis J; 2014 Jan; 33(1):63-9. PubMed ID: 24352189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count.
    Bigna JJ; Plottel CS; Koulla-Shiro S
    Infect Dis Poverty; 2016 Sep; 5(1):85. PubMed ID: 27593965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
    Dutta A; Barker C; Kallarakal A
    PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent costs of HIV/AIDS-related health services in Rwanda: implications for financing.
    Quentin W; König HH; Schmidt JO; Kalk A
    Trop Med Int Health; 2008 Oct; 13(10):1245-56. PubMed ID: 18721185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rwanda.
    United States. Department of State. Bureau of Public Affairs
    Backgr Notes Ser; 1985 Sep; ():1-4. PubMed ID: 12178061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges.
    Vitoria M; Vella S; Ford N
    Curr Opin HIV AIDS; 2013 Jan; 8(1):12-8. PubMed ID: 23188179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What makes orphans in Kigali, Rwanda, non-adherent to antiretroviral therapy? Perspectives of their caregivers.
    Kikuchi K; Poudel KC; Muganda J; Sato T; Mutabazi V; Muhayimpundu R; Majyambere A; Nyonsenga SP; Sase E; Jimba M
    J Int AIDS Soc; 2014; 17(1):19310. PubMed ID: 25477050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-Based Accompaniment Mitigates Predictors of Negative Outcomes for Adults on Antiretroviral Therapy in Rural Rwanda.
    Gupta N; Munyaburanga C; Mutagoma M; Niyigena JW; Kayigamba F; Franke MF; Hedt-Gauthier B
    AIDS Behav; 2016 May; 20(5):1009-16. PubMed ID: 26346334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Prevalence of Advanced HIV Disease at Antiretroviral Therapy Enrollment - 10 Countries, 2004-2015.
    Auld AF; Shiraishi RW; Oboho I; Ross C; Bateganya M; Pelletier V; Dee J; Francois K; Duval N; Antoine M; Delcher C; Desforges G; Griswold M; Domercant JW; Joseph N; Deyde V; Desir Y; Van Onacker JD; Robin E; Chun H; Zulu I; Pathmanathan I; Dokubo EK; Lloyd S; Pati R; Kaplan J; Raizes E; Spira T; Mitruka K; Couto A; Gudo ES; Mbofana F; Briggs M; Alfredo C; Xavier C; Vergara A; Hamunime N; Agolory S; Mutandi G; Shoopala NN; Sawadogo S; Baughman AL; Bashorun A; Dalhatu I; Swaminathan M; Onotu D; Odafe S; Abiri OO; Debem HH; Tomlinson H; Okello V; Preko P; Ao T; Ryan C; Bicego G; Ehrenkranz P; Kamiru H; Nuwagaba-Biribonwoha H; Kwesigabo G; Ramadhani AA; Ng'wangu K; Swai P; Mfaume M; Gongo R; Carpenter D; Mastro TD; Hamilton C; Denison J; Wabwire-Mangen F; Koole O; Torpey K; Williams SG; Colebunders R; Kalamya JN; Namale A; Adler MR; Mugisa B; Gupta S; Tsui S; van Praag E; Nguyen DB; Lyss S; Le Y; Abdul-Quader AS; Do NT; Mulenga M; Hachizovu S; Mugurungi O; Barr BAT; Gonese E; Mutasa-Apollo T; Balachandra S; Behel S; Bingham T; Mackellar D; Lowrance D; Ellerbrock TV
    MMWR Morb Mortal Wkly Rep; 2017 Jun; 66(21):558-563. PubMed ID: 28570507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
    Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
    Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.